BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Ultragenyx Pharmaceuticals Announces Results From Phase 1/2 Study Of KRN23 In X-Linked Hypophosphatemia In Adults

  June 24, 2014

   · 

  1 min read
• Business

  Core Diagnostics Appoints New CEO To Accelerate Growth

  June 24, 2014

   · 

  2 min read
• Almac Group’s Ground-Breaking AADX Gene Expression Marker Attracts Significant Commercial Interest From Pharma

  June 24, 2014

   · 

  5 min read
• Genetown

  Dart Therapeutics Changes Name To Akashi Therapeutics

  June 24, 2014

   · 

  1 min read
• FDA

  Hengrui Medicine Granted Approval To Market Cancer Drug In U.S.

  June 24, 2014

   · 

  1 min read
• FDA

  Abbott Medical Optics Receives CE Mark For TECNIS® Symfony Extended Range Of Vision Intraocular Lens For Cataract Patients

  June 24, 2014

   · 

  4 min read
• Business

  ThromboGenics NV Rules Out Sale, CFO Calls It Quits

  June 24, 2014

   · 

  4 min read
• Drug Development

  Ohr Pharmaceutical To Host Conference Call And Webcast To Discuss Squalamine Interim Phase 2 Data In Wet-AMD

  June 24, 2014

   · 

  1 min read
• Drug Development

  Ohr Pharmaceutical Eye Drug Falls Short In Phase 2 Trial

  June 24, 2014

   · 

  9 min read
• Biotech Bay

  Backed By New Investors Such As Lilly Ventures, Bay Area’s Numerate Secures $8 Million

  June 24, 2014

   · 

  3 min read